Martin Olovsson, Board member
Board member since 2018. Martin Olovsson holds a BSc in Business Administration from Lund University and has 25 years of experience in the pharmaceutical industry within AstraZeneca. The experience spans over responsibility for global launches, business development and operational roles, including as CEO of AstraZeneca Nordic-Baltic 2010 to 2013. Between 2014 and 2017, Martin was Global VP for the Respiratory Therapy area, with responsibility for leading the product and device development strategy including investments in Health tech. Martin has experience from major markets such as the US, Japan and the EU5. CEO of start-up company OnDosis since April 2017.